rfhg_189597.1

Basic information about the TSS

---

TSS ID: rfhg_189597.1 Species: human Chr: chr17		Start: 7857917 End: 7857934 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2906365,EH38E1844743)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC051846:26 GeneID: 84316 HGNC/MGI_ID: HGNC:28212 UniProt_ID: Nearer transcript ids and distances: ENST00000333775.9:63 BC033861:63 ENST00000575208.2:-145 ENST00000575071.5:355 BC006407:355 ENST00000575771.6:358 NM_032356.6:358 NM_001320924.3:358 NM_001320925.4:358 BC059944:426 KJ903414:454 KJ904915:454 AF530060:454 CU687386:454 KJ894981:494 DQ893290:494 DQ893319:494 DQ896634:494 view more...

Gene_name: N-alpha-acetyltransferase 38, NatC auxiliary subunit Gene_symbol: NAA38 Gene_synonyms: MGC14151 PFAAP2 Gene_source: HGNC:28212

TATA-Box annotation

---

Distance to TSS:	-34
Nearest PromoterID:	NM_001320925
Entrez ID:	84316
Nearest Unigene:	Hs.565094
Nearest Refseq:	NM_032356
Nearest Ensembl:	ENSG00000183011
Gene Name:	N-alpha-acetyltransferase 38, NatC auxiliary subunit
Gene Alias:	LSMD1|MAK31|PFAAP2
Gene Type:	protein-coding
CpG%:	0.058824
GC%:	0.444444
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p4@NAA38 p5@NAA38 p7@NAA38 p8@NAA38 p9@NAA38 p10@NAA38
Sample		p4@NAA38	p5@NAA38	p7@NAA38	p8@NAA38	p9@NAA38	p10@NAA38
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	43.25	30.00	3.51	0.39	0.78	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	39.05	32.17	3.84	0.40	0.81	2.83
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	28.94	27.01	1.93	1.35	0.39	2.31
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	32.64	24.53	1.04	0.21	0.00	2.70
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	40.72	29.25	2.70	0.67	0.00	4.27
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	31.78	26.16	3.10	0.39	0.97	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	43.79	41.40	2.40	1.53	1.09	4.58
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	44.33	33.67	2.91	0.48	1.94	2.66
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	47.02	38.26	3.42	1.07	0.85	3.42
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	29.56	28.40	1.74	0.00	1.74	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	28.30	17.79	1.21	0.00	0.81	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	22.77	15.04	1.63	0.00	0.41	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	56.42	17.41	3.22	1.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	40.14	12.93	2.41	1.50	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	54.67	16.91	3.29	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	40.49	12.83	2.77	2.01	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	47.61	15.29	4.59	1.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	41.76	17.72	3.37	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	46.38	11.20	2.67	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	58.97	18.05	3.31	1.20	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	47.45	15.37	2.27	2.00	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	58.52	17.95	3.11	1.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	36.45	12.41	1.94	1.68	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	43.19	13.10	3.40	1.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	46.70	12.64	4.90	2.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	55.71	23.11	3.80	1.58	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	44.51	19.23	2.75	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	47.86	18.62	2.36	1.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	46.52	19.06	2.10	1.78	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	50.85	17.55	2.71	0.90	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	51.71	13.40	1.88	2.51	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	49.82	20.71	3.32	2.54	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	48.96	18.57	4.01	1.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	38.60	15.67	2.64	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	50.86	13.28	2.80	0.93	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	48.10	15.14	4.02	2.49	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	53.14	16.35	4.09	1.43	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	39.89	10.68	2.42	1.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	64.01	16.75	1.89	1.89	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	46.09	21.37	4.08	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	39.52	11.29	3.06	2.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	36.01	17.57	1.61	1.02	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	45.97	16.87	2.74	1.90	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	50.87	15.56	2.62	1.75	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	51.60	21.28	3.21	2.01	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	60.95	19.08	1.63	2.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	46.30	17.75	3.60	1.92	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	64.68	25.93	3.28	2.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	47.64	16.76	2.39	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	49.94	16.98	1.01	0.81	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	57.80	16.40	1.23	0.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	54.04	15.57	4.00	2.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.84	10.65	4.61	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.52	11.60	1.99	1.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	8.39	6.71	0.84	2.52	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	26.64	11.48	1.84	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	27.87	5.19	3.24	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	29.23	7.07	3.85	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	36.78	10.06	2.51	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.15	7.76	3.53	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.95	7.29	1.12	2.24	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	3.18	6.37	0.80	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.37	7.81	1.02	0.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.70	6.82	4.87	2.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	9.58	3.55	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	10.73	8.78	2.93	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	13.88	7.44	1.49	1.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	7.04	2.81	0.47	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.89	8.61	4.31	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	18.87	6.50	2.78	2.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.15	6.42	3.06	3.06	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	51.79	20.91	1.43	0.16	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	56.15	16.20	1.44	0.96	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	41.86	15.39	1.27	0.25	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	68.77	14.95	0.75	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	48.56	17.42	2.34	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	55.51	15.31	2.55	3.19	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	63.77	9.90	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	75.87	13.55	0.00	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	88.80	12.51	1.39	0.70	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	16.04	14.47	3.91	0.59	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	19.30	11.32	4.12	1.29	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	29.83	12.27	1.39	0.28	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	27.63	14.11	2.35	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	19.38	13.11	1.53	0.08	0.24	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	26.47	11.94	1.29	0.65	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	16.00	10.66	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	27.82	14.47	1.11	0.00	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	45.33	19.13	0.00	1.66	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	17.33	12.06	2.26	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	19.96	9.16	0.65	0.65	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	20.70	9.13	0.91	0.00	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	51.27	37.79	1.77	0.00	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	92.51	49.48	1.43	0.72	1.79	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	29.95	11.98	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	51.09	37.42	3.06	0.72	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	58.57	33.47	3.35	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	50.54	24.45	5.14	0.21	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	43.37	18.77	5.72	2.17	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	50.45	16.16	3.18	1.71	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	84.92	31.00	2.25	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	79.01	30.39	1.74	1.30	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	81.33	29.96	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	72.04	32.58	1.49	0.30	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	72.09	37.94	5.06	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	116.17	38.94	2.64	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	73.10	28.27	1.30	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	97.09	42.72	1.46	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	72.45	38.01	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	76.83	35.03	0.75	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	72.57	26.12	0.73	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	84.00	47.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	54.69	34.43	2.80	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	87.35	25.93	2.73	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	115.05	43.58	2.71	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	79.83	32.68	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	82.75	33.82	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	80.72	35.55	3.47	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	79.01	29.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	70.66	33.50	2.82	0.66	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	85.25	27.62	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	95.58	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	74.10	29.67	0.86	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	71.31	37.75	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	85.43	24.27	0.97	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	70.96	34.15	1.90	0.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	83.58	29.07	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	82.08	31.35	2.28	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	82.30	35.49	1.92	0.00	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	85.69	30.71	2.32	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	88.68	32.38	2.35	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	67.85	30.55	2.25	0.64	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	87.04	34.25	1.43	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	77.80	32.17	0.58	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	73.76	31.61	2.41	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	112.86	32.08	4.75	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	91.54	36.11	3.05	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	79.97	34.64	1.53	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	79.42	33.04	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	77.24	38.84	1.73	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	77.48	35.14	2.33	1.27	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	84.96	25.23	2.03	1.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	76.52	26.45	4.72	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	76.79	30.01	0.68	0.17	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	97.29	30.11	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	73.94	21.13	0.00	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	71.61	29.16	2.14	0.64	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	90.85	31.29	3.61	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	79.46	29.89	2.92	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	72.41	37.01	2.30	0.69	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	56.11	38.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	127.12	41.95	0.76	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	75.76	30.97	3.10	0.62	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	89.05	33.66	2.45	0.61	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	80.31	32.98	2.39	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	70.96	25.06	2.00	0.89	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	105.28	47.30	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	81.98	26.59	1.66	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	65.40	35.48	2.12	1.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	77.41	35.62	2.18	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	92.97	29.11	6.63	1.84	0.12	0.12
Astrocyte - cerebellum, donor2	11580-120F5	134.87	36.80	5.48	2.74	0.34	0.34
Astrocyte - cerebellum, donor3	11661-122F5	42.37	21.39	13.21	5.03	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	66.58	18.48	5.93	6.27	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	71.50	37.53	2.91	0.65	0.49	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	74.43	24.01	4.33	1.04	0.15	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	40.03	38.42	3.78	1.38	0.46	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	49.49	45.73	5.14	1.00	0.63	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	51.89	44.61	2.84	1.48	0.46	1.14
Basophils, donor1	12241-129G9	27.98	12.82	1.31	0.00	2.88	0.00
Basophils, donor2	12242-129H1	20.57	6.86	1.80	0.00	2.89	0.00
Basophils, donor3	12243-129H2	14.99	9.85	1.18	0.00	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	23.93	8.19	0.43	0.65	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	126.18	32.92	3.20	1.83	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	125.53	42.05	0.63	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	69.04	25.58	2.08	1.25	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	23.95	12.21	0.92	1.61	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	31.13	7.92	0.72	0.18	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	108.10	70.59	6.18	0.41	0.62	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	147.89	65.91	7.69	2.33	0.00	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	320.09	59.48	5.12	0.64	1.28	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	175.81	0.00	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.16	6.76	0.56	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	11.69	7.61	0.56	0.19	0.74	0.19
CD14+ Monocytes, donor3	11381-118B4	12.73	10.10	1.98	0.22	1.10	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	47.55	13.59	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	31.84	14.03	1.14	0.00	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	35.50	9.20	1.31	0.33	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	9.25	6.36	0.87	0.29	1.30	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	4.83	5.13	0.60	0.30	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	6.87	4.97	0.00	0.00	2.13	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.86	5.52	0.67	0.00	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.62	4.42	0.55	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	7.44	6.94	0.25	0.00	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.62	5.87	0.78	0.00	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.44	4.99	0.89	0.00	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.76	11.10	1.52	0.00	1.31	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.56	6.32	0.47	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.45	7.92	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	6.66	6.66	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	8.48	4.61	0.59	0.15	0.45	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.19	3.79	0.60	0.00	0.80	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.33	5.83	0.42	0.00	0.83	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.75	7.78	0.69	0.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.24	4.98	0.68	0.00	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.98	3.49	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.72	6.99	0.81	0.00	1.34	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.47	7.33	0.87	0.17	1.05	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.52	4.63	0.84	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	7.90	8.63	0.73	0.18	0.73	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.05	4.23	0.70	0.00	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.83	6.58	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	15.34	7.85	1.22	0.35	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.04	5.95	1.49	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	16.81	8.19	0.00	0.00	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	12.28	5.73	0.82	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	7.88	3.48	0.00	0.23	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	9.51	5.34	0.70	0.00	1.62	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	42.50	16.78	1.31	0.22	2.83	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	41.35	22.87	1.62	0.00	1.62	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	66.72	16.25	0.22	0.00	1.73	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	43.13	29.90	1.09	0.31	5.45	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	55.19	24.28	0.87	0.17	2.27	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	42.81	10.48	0.67	0.00	2.01	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	135.50	39.04	1.02	0.26	4.59	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	73.33	26.35	1.32	0.22	3.73	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	105.69	19.58	0.84	0.00	2.53	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	113.81	14.23	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	103.05	20.34	2.03	0.00	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	86.99	20.71	2.07	0.00	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	98.61	38.38	0.53	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	102.92	16.08	1.07	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	106.69	25.27	0.70	0.00	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	92.55	26.67	1.57	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	114.69	23.73	0.00	1.32	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	28.77	6.58	4.11	0.00	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	17.41	5.08	1.45	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	19.69	4.04	0.50	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	29.09	21.01	0.00	0.00	0.81	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	41.95	28.76	0.40	0.00	1.20	1.60
CD34+ Progenitors, donor1	11545-120B6	181.73	37.15	2.01	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	63.48	8.43	0.00	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	235.60	58.99	3.38	2.25	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	276.67	70.13	2.25	0.90	1.13	0.68
CD4+ T Cells, donor1	11225-116C1	23.57	2.14	2.14	0.00	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	33.68	2.45	0.61	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	32.02	2.13	1.22	0.30	0.30	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	64.06	12.51	1.79	0.26	0.77	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	92.31	12.58	4.94	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	83.08	6.90	4.31	0.29	1.15	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	69.69	5.22	1.90	0.00	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	91.30	7.02	3.51	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	65.92	0.00	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	53.76	12.28	2.17	0.58	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	109.81	20.50	2.88	0.34	0.34	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	108.01	17.57	2.58	0.64	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	67.69	5.38	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	68.83	6.64	2.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	57.64	4.40	1.76	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	64.09	8.43	2.95	0.42	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	130.48	17.66	4.78	1.25	1.25	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	136.99	18.04	7.35	0.33	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	48.40	5.17	0.00	0.00	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	51.45	6.43	2.14	0.00	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	48.42	10.76	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	94.20	18.73	4.08	0.19	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	141.88	14.08	4.55	0.22	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	109.91	15.55	6.51	0.21	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	80.39	13.65	0.00	0.00	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	83.62	7.80	2.17	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	48.81	3.49	2.61	0.44	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	108.87	16.33	3.96	0.00	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	111.71	15.69	1.85	0.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	125.62	15.35	2.79	0.00	4.19	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	98.03	6.37	3.32	0.00	1.11	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	95.95	4.66	3.93	0.74	0.98	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	117.04	10.78	10.78	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	96.69	15.40	3.94	0.72	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	145.42	29.08	4.15	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	27.17	5.89	2.62	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	26.66	1.88	2.25	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	25.25	4.54	2.78	0.25	0.25	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	35.33	13.30	3.44	2.52	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	29.96	9.59	2.88	1.44	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	36.93	14.77	1.92	1.37	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	22.82	10.81	0.90	1.80	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	54.24	12.72	3.84	3.84	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	27.97	10.91	2.73	4.32	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	37.59	14.56	3.69	2.39	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	31.32	13.95	3.68	2.63	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	38.23	14.77	2.35	0.94	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	65.51	17.21	1.51	1.81	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	53.45	22.66	2.03	2.32	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	49.02	19.98	1.87	1.87	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	27.14	6.57	0.44	4.38	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	20.49	5.47	1.82	3.19	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.88	4.48	1.49	3.73	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.13	10.08	2.16	2.52	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	33.95	9.49	3.45	0.86	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	27.11	10.84	3.54	3.54	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.99	11.09	3.17	2.22	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	31.99	12.92	6.46	3.08	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	26.29	8.34	1.92	0.64	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	37.48	15.68	4.21	0.38	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	43.75	14.98	4.34	1.58	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	40.85	15.13	3.03	2.27	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.09	4.82	1.61	5.62	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	3.50	6.29	4.90	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	7.01	5.01	2.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	32.90	9.14	3.66	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	100.30	41.01	5.93	1.98	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	47.46	25.36	7.05	0.74	0.32	0.21
Chondrocyte - de diff, donor1	11261-116G1	42.64	13.17	0.69	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	47.98	18.48	2.49	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	42.55	14.22	1.25	0.23	0.34	0.11
Chondrocyte - re diff, donor2	11339-117F7	34.02	19.70	1.79	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	41.25	18.20	2.43	1.62	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	61.05	31.44	4.48	1.15	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	60.92	39.33	4.28	1.50	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	55.40	30.53	5.22	2.12	0.00	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	37.32	21.64	2.11	2.57	0.37	5.78
Corneal Epithelial Cells, donor1	11526-119I5	67.19	25.69	2.63	0.88	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	63.71	23.89	1.14	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	69.28	35.79	1.53	0.51	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	32.03	11.72	0.99	0.17	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	38.16	13.56	0.32	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	13.80	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.07	7.67	0.11	0.11	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	51.93	8.20	1.71	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	73.77	10.45	0.65	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	80.82	4.36	1.45	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	51.20	38.52	3.67	0.33	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	96.82	37.55	4.11	0.59	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	62.78	24.89	3.96	0.00	0.57	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	62.91	55.83	2.75	0.00	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	90.17	36.36	2.62	0.87	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	100.70	33.41	6.82	0.71	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	60.66	38.22	2.28	0.70	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.56	23.72	4.43	0.22	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	34.99	16.73	2.74	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	30.73	15.22	2.82	0.56	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	81.71	34.76	1.19	1.49	0.89	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	121.31	46.86	4.17	1.56	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	78.83	37.01	3.83	0.99	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	65.62	30.01	2.80	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	85.96	46.12	4.19	1.05	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	43.98	27.96	8.57	1.12	0.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	58.01	33.89	13.90	1.30	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	57.40	30.41	9.89	1.95	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	58.01	36.40	6.83	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	49.59	40.51	4.19	0.70	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	85.25	34.07	8.32	2.04	0.31	0.31
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	8.25	9.90	0.00	0.00	16.50	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.89	16.37	1.95	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	8.32	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.95	13.55	5.34	0.82	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	63.07	25.84	2.52	0.44	0.00	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	89.92	30.88	5.63	1.63	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	39.90	26.56	3.52	0.97	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	18.97	11.60	0.27	0.27	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	30.38	18.77	2.21	0.95	0.42	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.71	7.64	1.84	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	53.15	20.26	4.32	1.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	44.91	33.57	0.91	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	41.69	31.83	5.31	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	68.92	37.38	3.00	0.63	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	40.92	19.40	3.03	0.30	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	72.21	20.43	4.70	0.76	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	102.93	33.96	5.91	1.21	0.15	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	28.94	10.85	4.02	2.55	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.53	9.92	7.33	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	76.17	30.76	4.39	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	58.12	17.99	1.61	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	21.88	7.12	4.58	0.68	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	86.63	18.55	0.70	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	82.07	30.19	2.83	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	66.49	21.03	0.85	0.24	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	73.37	21.25	1.36	0.68	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	73.44	23.38	0.70	0.35	0.52	0.35
Fibroblast - Dermal, donor6	11458-119A9	85.76	26.15	0.65	0.49	0.16	0.97
Fibroblast - Gingival, donor1	11237-116D4	40.19	16.87	2.08	0.83	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	73.62	19.39	1.57	0.79	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	75.25	36.11	1.84	1.05	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	32.49	8.03	1.74	0.58	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	28.05	14.54	3.12	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	27.14	16.56	3.00	1.41	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	117.86	28.68	3.27	0.31	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	97.77	19.20	1.62	0.27	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	26.11	13.76	2.82	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	162.33	26.47	2.19	1.32	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	121.49	28.50	2.73	0.55	0.41	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	120.77	23.80	2.08	0.55	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	61.19	8.95	4.11	1.32	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	38.06	33.98	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	13.43	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	62.26	23.42	3.17	1.06	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	61.64	19.99	0.00	0.00	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	33.57	8.39	2.80	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	60.45	26.87	1.68	0.84	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	40.19	18.67	1.22	0.81	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	79.88	27.96	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	23.83	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	64.21	29.29	2.52	0.58	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	77.66	32.76	2.12	0.76	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	28.46	10.71	0.31	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	62.59	15.65	3.82	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	73.44	26.46	3.24	1.35	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.78	14.26	2.78	0.70	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	72.62	48.30	2.65	0.55	0.88	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	37.59	22.35	1.02	0.61	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	100.23	29.40	1.34	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	77.49	27.68	3.16	0.40	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.30	5.75	0.20	0.40	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.89	8.53	2.84	0.89	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	32.32	13.99	1.97	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.66	9.03	0.30	0.30	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	33.57	12.31	1.73	0.43	0.32	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	15.18	5.06	0.25	0.00	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	25.27	12.80	1.64	0.82	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	23.66	14.24	0.80	0.00	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	32.75	18.49	0.80	0.40	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	19.95	6.95	0.91	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	25.35	11.10	2.32	0.75	0.25	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	39.32	13.51	1.20	1.20	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	14.12	8.21	0.33	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	37.60	16.51	0.85	0.11	0.21	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	47.23	27.33	1.52	0.17	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	26.35	13.49	1.57	0.00	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	41.83	5.23	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.23	25.66	1.73	0.69	1.91	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	24.72	19.78	1.56	0.26	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	25.81	27.34	0.26	0.26	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	40.57	23.73	6.89	2.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	24.25	22.97	1.28	0.64	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	79.59	30.52	1.71	0.00	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	28.68	11.58	3.86	2.76	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	38.13	15.07	9.59	2.51	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	56.27	24.77	2.97	1.39	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	29.34	10.31	3.44	1.32	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	38.49	21.20	7.50	1.96	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	142.40	54.84	0.00	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	18.94	9.89	2.83	1.55	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	18.47	9.24	3.57	2.22	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.75	12.63	0.54	0.81	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.85	7.31	5.33	1.36	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	12.46	7.48	3.74	0.83	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	9.96	8.95	1.22	0.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	25.10	6.85	4.56	1.83	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	10.96	3.99	2.87	1.62	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.37	4.15	1.09	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.96	8.57	8.57	4.43	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	22.10	7.31	5.56	3.97	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.63	6.70	4.47	1.79	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.84	7.06	10.08	4.03	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	27.82	11.20	6.28	3.73	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	13.12	6.92	4.17	1.95	0.35	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.27	5.83	6.97	4.58	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.52	5.98	4.78	4.95	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	21.13	5.98	7.75	3.65	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.38	8.24	6.07	2.25	0.00	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.13	5.72	5.51	2.86	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	26.82	9.28	8.25	4.75	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.75	6.11	9.34	6.11	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.51	8.67	6.84	3.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.89	6.83	10.14	3.09	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.07	5.78	10.70	4.92	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.69	11.35	7.13	1.95	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	48.43	6.41	9.94	5.77	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	26.34	8.43	7.11	2.84	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	22.62	9.02	6.64	1.74	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	38.62	10.34	9.43	4.56	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	16.73	7.21	5.23	2.93	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	25.91	6.81	7.90	3.07	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	28.62	7.86	5.05	1.96	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	20.65	10.83	4.72	1.02	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.34	9.36	1.60	1.07	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	26.32	10.71	3.83	0.92	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	24.09	9.20	5.18	1.42	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.94	4.88	6.51	2.17	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	23.60	12.72	8.48	2.58	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.71	8.11	6.36	1.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	2.98	4.96	5.95	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	28.89	9.76	5.14	0.79	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	43.18	8.68	5.65	1.82	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	12.71	3.30	3.81	1.27	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	12.94	10.75	1.00	0.00	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	9.71	7.09	0.62	0.46	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	19.03	12.68	1.84	0.82	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	66.34	38.49	2.19	0.94	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	64.42	40.97	1.98	0.85	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	54.88	20.29	0.92	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	44.55	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	39.84	33.27	3.09	1.55	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	64.18	49.74	12.84	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	52.16	15.65	5.22	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	57.94	29.29	3.91	1.95	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	40.36	24.71	5.77	2.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	29.99	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	53.41	28.52	6.71	3.36	0.84	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	39.55	22.23	7.84	1.31	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	53.69	12.58	4.19	2.52	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.71	24.17	7.95	1.91	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	56.72	28.19	10.87	0.68	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	137.82	25.06	4.18	8.35	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	67.58	29.78	8.02	3.44	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	58.31	18.65	8.58	2.37	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	86.40	35.58	8.47	6.78	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	58.82	38.52	10.36	4.56	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.42	37.51	9.90	2.76	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	115.91	21.07	5.27	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	53.43	29.98	10.38	7.30	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	59.33	34.88	13.36	3.59	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	104.34	36.79	19.40	4.68	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	58.56	18.11	8.86	6.55	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	38.34	20.20	17.46	5.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	96.91	12.42	29.82	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	81.16	18.40	12.74	5.19	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	65.18	18.71	16.29	6.64	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	87.49	19.84	12.72	6.61	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	93.73	21.14	10.77	7.58	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	76.96	22.20	25.16	5.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	95.62	17.71	5.90	11.80	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	115.52	19.25	8.17	11.09	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	65.83	10.53	12.73	3.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	83.07	9.32	6.78	8.48	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	55.51	22.09	13.13	5.37	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	71.33	34.45	9.22	3.40	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	76.47	28.53	2.28	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	63.20	23.70	4.99	2.49	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	61.84	55.10	3.37	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	53.60	15.54	5.07	1.27	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	76.03	25.06	2.09	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	135.19	71.60	0.70	0.81	1.39	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	127.78	58.57	0.84	0.17	1.35	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	114.21	53.01	0.00	0.46	1.14	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	138.06	71.49	0.33	0.33	1.75	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	118.85	59.96	0.64	0.43	1.50	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	111.52	50.38	0.22	0.43	1.51	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	150.57	82.94	1.00	0.12	1.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	123.52	59.01	1.03	0.00	1.54	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	116.62	48.70	0.96	0.00	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	60.44	21.83	12.87	3.92	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	40.68	29.43	9.52	1.73	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	132.19	52.88	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	47.62	43.38	3.53	0.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	66.11	26.88	8.72	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	64.87	39.86	2.10	0.35	0.87	0.00
Hepatocyte, donor1	11523-119I2	61.74	23.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	59.25	11.85	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	18.41	17.79	2.45	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	50.26	24.80	2.61	0.00	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	4.89	6.47	0.35	0.17	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	55.29	25.79	3.16	0.27	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	22.29	6.37	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	13.35	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	24.92	2.77	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	12.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	25.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	13.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	16.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	16.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	18.53	3.97	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	12.20	16.63	1.11	0.00	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	22.05	24.56	1.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	20.11	3.09	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	11.63	14.21	3.23	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	17.71	3.22	0.00	0.00	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	19.56	16.30	2.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	8.40	14.69	0.42	0.00	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	16.88	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	17.54	1.85	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	21.24	3.30	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	12.70	0.91	0.00	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	22.60	2.15	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	24.14	2.54	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.93	16.58	1.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	23.69	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	15.71	1.43	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	23.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.98	20.37	2.16	0.62	0.00	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	19.32	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	18.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	13.21	17.38	0.70	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	13.28	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	16.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	5.23	11.34	3.49	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	27.00	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	20.91	0.00	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	5.33	1.07	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	9.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	8.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.97	20.25	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	27.23	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	18.63	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	8.46	1.06	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	23.42	17.63	0.90	0.08	0.24	0.00
Keratinocyte - epidermal, donor2	11349-117G8	19.33	11.13	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	54.33	25.08	0.47	0.19	0.28	0.28
Keratinocyte - oral, donor1	11251-116E9	27.58	17.71	2.95	0.91	0.23	0.11
Keratocytes, donor1	11527-119I6	18.91	8.25	4.13	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	69.14	24.61	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	11.26	3.75	2.37	1.19	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	35.17	10.99	2.20	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	72.28	31.28	4.31	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	23.53	13.03	3.92	3.23	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	32.49	22.81	2.62	0.50	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	44.23	35.10	1.19	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	51.91	41.02	1.67	1.40	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	47.22	48.01	3.31	0.79	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	70.98	44.63	2.69	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	54.21	46.33	2.21	0.95	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	53.37	56.06	3.99	0.65	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.53	33.65	3.28	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	67.25	48.54	2.28	1.26	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	45.18	47.15	4.50	1.13	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	42.72	31.64	3.16	1.19	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	54.48	43.43	2.71	1.55	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	59.80	60.36	4.44	0.93	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	53.66	44.60	1.39	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	48.18	43.89	4.53	1.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	51.37	54.53	2.61	0.82	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	49.58	42.19	1.85	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	64.22	50.19	5.30	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	55.63	60.20	4.57	1.10	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	55.29	44.43	2.96	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	62.67	51.55	3.22	0.59	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	58.50	61.98	2.99	0.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	51.41	44.62	2.42	1.94	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	52.51	42.82	2.96	1.62	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	53.44	51.92	2.27	1.36	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	51.84	37.84	3.11	1.04	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	59.68	38.74	2.93	1.05	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	56.99	53.08	3.46	0.90	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	47.46	38.52	2.06	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	41.20	39.51	4.70	1.13	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	54.29	52.59	3.92	1.06	0.21	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	47.49	28.59	1.45	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	37.05	35.06	3.31	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	52.28	51.29	4.34	1.24	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	60.34	36.28	4.07	1.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	44.47	35.83	2.22	0.99	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	51.84	52.66	4.12	1.10	0.82	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	43.74	43.42	3.86	1.29	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	47.78	34.69	4.26	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	63.68	50.39	3.36	1.26	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	46.93	39.47	4.27	0.71	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	50.42	36.36	4.85	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	64.89	66.44	5.91	1.56	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	58.37	39.03	3.58	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	41.49	39.53	3.59	0.65	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	74.86	62.15	4.00	0.94	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	40.71	32.30	3.09	1.86	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	37.91	35.60	2.82	1.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	54.90	46.54	3.58	1.79	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	90.64	90.64	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	79.78	62.90	3.84	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	86.84	66.06	2.23	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	79.97	74.05	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	104.09	64.71	1.41	0.00	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	63.51	55.10	1.87	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	70.08	58.23	0.52	1.03	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	74.94	76.13	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	60.85	76.23	2.26	0.23	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	81.72	66.02	4.36	1.16	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	81.93	67.98	3.15	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	50.81	67.61	3.12	0.54	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	88.33	72.41	3.59	0.51	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	67.04	58.93	1.06	1.06	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	95.28	36.65	2.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	84.05	63.67	2.55	0.51	1.02	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	77.91	61.90	1.33	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	82.57	62.35	2.65	0.76	0.38	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	61.36	77.92	0.00	0.61	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	69.31	82.36	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	82.26	68.93	1.67	0.42	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	83.80	60.82	2.52	0.56	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	72.12	51.52	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	84.77	79.54	2.32	0.29	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	79.22	79.22	1.49	0.60	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	75.80	53.11	1.66	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	62.57	65.04	3.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	86.29	68.96	1.84	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	77.14	67.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	89.03	67.54	1.15	0.77	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	68.50	72.46	1.13	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	98.46	71.38	0.82	0.00	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	62.81	74.11	2.71	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	91.20	74.69	2.15	0.72	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	97.84	56.02	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	69.86	63.91	3.72	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	77.97	74.09	1.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	91.62	59.94	1.71	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	96.95	82.96	1.33	1.00	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	92.31	74.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	81.05	65.41	2.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	80.43	70.12	2.41	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	84.27	60.65	2.68	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	75.42	69.36	6.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	87.42	75.56	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	68.61	94.20	2.33	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	80.39	69.81	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	77.23	69.63	4.40	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	82.14	69.78	2.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	85.85	82.78	2.30	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	86.32	77.94	0.00	0.00	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	78.10	63.98	2.82	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	74.92	85.48	2.01	1.01	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	74.35	64.89	1.80	0.45	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	55.08	56.80	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	78.38	76.60	3.56	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	69.99	71.56	1.96	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	73.89	69.93	2.64	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	94.44	98.08	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	59.95	76.57	1.75	0.00	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	83.87	71.56	1.12	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	81.70	81.70	2.65	0.00	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	86.01	91.03	1.54	1.16	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	80.51	65.83	0.51	0.51	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	80.26	78.82	2.88	0.48	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	78.32	80.70	1.99	0.40	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	71.70	53.47	2.43	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	76.78	44.96	0.69	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	90.82	79.04	1.14	0.76	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	79.53	67.13	0.52	1.03	0.52	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	78.61	45.35	1.81	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	71.62	77.64	1.27	0.32	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	68.77	57.04	1.60	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	47.70	51.15	1.15	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	71.48	60.68	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	76.39	74.27	1.41	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	64.13	59.02	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	71.14	63.65	0.83	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	74.39	55.60	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	66.81	55.12	1.25	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	68.77	67.37	0.46	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	73.60	68.24	2.68	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	85.01	68.97	0.53	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	58.19	69.91	2.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	66.08	55.98	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	67.57	48.01	2.67	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	81.49	71.80	3.99	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	67.49	55.98	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	70.59	61.83	2.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	59.69	67.26	0.89	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	62.91	92.02	2.86	0.26	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	90.85	65.65	2.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	91.46	103.93	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	13.90	10.26	0.46	0.00	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	19.45	16.88	0.55	0.37	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	25.43	24.91	1.05	0.00	0.92	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	38.76	55.76	3.72	1.06	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	9.19	16.48	1.74	0.00	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	18.21	25.71	0.42	0.14	0.42	0.42
Mammary Epithelial Cell, donor1	11273-116H4	43.74	21.62	1.10	0.30	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	48.64	21.72	0.00	0.58	0.00	0.87
Mammary Epithelial Cell, donor3	11422-118F9	53.88	44.90	0.50	0.25	1.00	0.00
Mast cell - stimulated, donor1	11487-119E2	25.08	16.95	0.68	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	44.01	11.90	1.95	0.22	0.11	0.00
Mast cell, donor2	11565-120D8	17.24	2.38	1.49	0.30	0.59	0.00
Mast cell, donor3	11566-120D9	28.14	2.48	2.03	0.68	0.23	0.00
Mast cell, donor4	11567-120E1	23.40	3.55	1.60	0.53	0.35	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	21.62	15.41	0.22	0.11	0.11	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	43.78	11.67	1.75	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	73.31	19.27	2.18	0.23	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	46.53	18.58	3.68	0.00	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	85.47	43.28	3.48	1.09	0.40	0.20
Melanocyte - dark, donor2	11582-120F7	90.67	45.68	6.92	1.38	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	45.20	13.98	0.94	0.36	0.22	0.14
Melanocyte - light, donor1	11274-116H5	35.03	7.05	0.94	1.65	0.24	0.00
Melanocyte - light, donor2	11351-117H1	33.44	19.79	0.00	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	48.56	17.34	4.34	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	51.13	16.66	1.56	0.62	0.10	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	102.20	39.27	4.57	0.81	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	54.64	12.86	1.34	0.27	0.27	0.27
Meningeal Cells, donor1	11493-119E8	63.15	21.34	4.47	1.24	0.00	0.50
Meningeal Cells, donor2	11573-120E7	76.59	24.65	5.72	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	52.98	24.29	3.34	0.49	0.33	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	101.23	28.80	5.42	0.86	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	45.49	19.72	1.91	0.91	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	187.93	44.68	7.88	5.26	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	156.98	45.79	2.62	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	89.70	36.60	4.31	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.13	11.44	2.96	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	40.71	18.60	2.51	0.00	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	96.25	34.72	1.98	0.88	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	89.13	31.42	2.92	1.46	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	96.16	36.21	1.64	0.61	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	34.90	9.56	2.08	0.42	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	33.83	22.68	5.20	2.97	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.95	8.16	7.24	2.37	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.42	13.95	4.75	1.78	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	11.68	2.34	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	101.82	42.91	5.76	0.00	2.56	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	74.79	35.09	2.48	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.45	14.07	5.94	2.50	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	97.24	34.11	2.18	0.73	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	35.27	32.62	2.39	0.80	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	43.54	36.03	1.50	0.50	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	31.29	23.12	2.02	0.51	0.29	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	37.81	25.66	4.05	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	37.19	18.72	1.72	0.25	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	38.87	23.85	1.18	0.88	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	10.37	10.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	35.02	21.08	0.62	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.04	15.56	0.41	0.21	1.04	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	13.90	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	60.56	16.02	2.25	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	27.93	20.48	1.86	0.47	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	44.10	15.44	0.81	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	28.91	18.61	0.79	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	39.82	14.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	44.83	23.56	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	23.69	2.63	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	29.07	15.28	0.64	0.42	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	15.65	18.42	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	29.21	9.84	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	13.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	41.90	15.31	1.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.96	14.26	0.24	0.00	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	8.85	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	29.93	13.58	0.69	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	27.76	19.35	0.21	0.21	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	34.85	10.60	1.22	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	37.54	14.37	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.45	15.78	0.67	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	27.82	11.61	0.88	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.69	21.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	11.60	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	26.91	11.42	0.54	0.00	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.41	12.94	1.18	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	16.35	5.45	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	34.12	14.42	1.92	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.42	17.21	0.40	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	4.11	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	48.06	14.52	2.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	2.04	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	32.41	10.95	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.33	8.97	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	33.22	13.14	0.25	0.50	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	11.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	11.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.22	10.60	1.37	0.34	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.88	12.69	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.20	9.94	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.62	13.47	0.28	0.56	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	13.30	12.05	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	7.58	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.07	9.35	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.94	9.60	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	10.16	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	14.23	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.17	11.19	0.69	0.55	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.99	11.66	0.26	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.58	12.44	0.86	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	12.70	1.27	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.08	10.14	0.53	0.27	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	23.95	12.57	2.10	1.50	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.42	10.45	1.41	0.42	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	29.62	11.47	0.64	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.24	19.90	0.00	0.22	1.11	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.24	12.51	1.52	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	30.12	13.64	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	19.17	16.22	0.49	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	7.82	1.30	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	28.23	15.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	24.80	13.55	0.86	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	13.19	11.54	2.47	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.72	15.19	0.00	0.89	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	97.94	41.44	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	130.10	19.60	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	55.86	14.46	0.66	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	105.20	25.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	74.92	22.73	0.99	0.00	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	81.96	15.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	81.49	17.65	0.38	0.00	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	64.45	21.57	0.53	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	38.57	12.33	0.68	0.00	1.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	81.78	12.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	79.88	14.66	1.47	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	12.44	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	72.15	16.03	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	115.92	30.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	69.69	18.18	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	68.73	17.29	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	84.44	12.26	1.36	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	74.39	13.99	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	109.33	21.06	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	96.67	15.10	4.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	22.84	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	23.05	21.33	4.09	0.00	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.59	9.41	1.05	2.09	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	38.71	2.67	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.96	7.51	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	65.41	22.06	2.09	0.00	0.57	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	98.94	51.07	9.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	26.52	9.52	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	7.35	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.95	6.28	1.67	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	60.90	16.97	2.09	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	33.24	6.76	3.51	1.89	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	65.38	23.34	3.78	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	49.64	13.90	1.49	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	31.94	8.93	1.62	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	39.90	7.48	1.36	0.45	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	21.56	4.25	3.10	0.65	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	29.16	12.58	3.10	0.91	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	34.48	6.90	3.71	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	27.61	7.20	1.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	31.83	9.19	2.95	0.00	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	32.04	7.97	0.81	0.98	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.10	11.82	2.29	0.35	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	24.61	5.63	4.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	38.16	3.68	3.68	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.99	3.21	3.53	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.87	7.59	0.69	0.69	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	2.53	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.96	11.58	4.23	0.22	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	32.60	3.81	5.08	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	37.98	7.36	1.90	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	30.48	4.72	3.43	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	53.32	5.33	5.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	27.05	7.66	2.71	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.95	5.56	2.38	0.79	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	45.50	3.71	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.24	9.84	7.57	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.16	6.19	2.28	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	38.78	3.49	1.74	1.74	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	22.61	9.05	4.07	1.81	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	23.81	2.65	3.53	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.25	4.65	1.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	63.99	3.47	1.49	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	29.86	3.06	1.91	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	37.50	3.33	3.33	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.54	13.04	2.43	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	31.85	4.74	3.39	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	5.11	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	42.68	5.49	5.49	2.44	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	30.21	6.92	5.35	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.00	1.21	4.84	1.21	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	5.54	1.58	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	7.94	3.40	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	43.85	24.97	1.99	0.25	0.00	0.12
Myoblast, donor2	11322-117D8	43.15	26.85	2.88	0.58	0.00	0.19
Myoblast, donor3	11398-118D3	43.39	18.16	1.85	0.34	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	199.49	15.03	9.63	0.29	0.44	0.00
Natural Killer Cells, donor1	11230-116C6	28.29	3.38	1.54	0.00	0.31	0.92
Natural Killer Cells, donor2	11311-117C6	31.36	4.22	2.41	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	19.14	4.42	3.68	0.00	0.37	1.10
Neural stem cells, donor1	11275-116H6	25.77	18.51	3.63	1.81	0.36	0.00
Neural stem cells, donor2	11352-117H2	15.41	11.55	1.93	5.78	0.00	0.00
Neurons, donor1	11494-119E9	29.59	22.76	3.41	3.41	0.00	0.00
Neurons, donor2	11574-120E8	25.76	25.54	1.76	1.32	0.00	0.22
Neurons, donor3	11655-122E8	47.69	30.42	7.40	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	4.64	1.86	0.00	0.00	2.78	0.93
Neutrophils, donor2	11314-117C9	0.00	8.70	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.67	4.89	1.22	0.00	3.05	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	22.08	11.28	5.82	2.14	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	67.73	16.93	12.37	4.23	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	39.11	13.44	5.82	2.21	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	23.68	13.77	4.82	0.69	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	43.86	24.90	3.76	0.87	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	34.51	19.86	3.86	0.57	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	50.45	19.87	3.12	1.46	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	30.69	18.66	2.41	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	45.73	14.68	1.70	1.49	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	124.60	17.15	5.72	2.29	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	113.59	20.48	7.45	3.10	1.86	0.00
Osteoblast, donor1	11277-116H8	130.94	89.90	6.25	1.76	0.20	0.00
Osteoblast, donor2	11354-117H4	41.44	19.66	1.40	0.00	1.40	0.00
Osteoblast, donor3	11426-118G4	64.16	34.48	4.62	0.36	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	26.96	16.76	1.26	0.34	0.08	0.00
Pericytes, donor1	11491-119E6	48.07	13.57	4.23	1.89	0.33	0.11
Pericytes, donor2	11571-120E5	59.53	8.15	4.07	3.17	0.00	0.00
Pericytes, donor3	11652-122E5	58.39	33.37	8.34	1.22	0.20	0.20
Perineurial Cells, donor1	11499-119F5	40.80	14.92	4.86	0.90	0.45	0.11
Perineurial Cells, donor2	11579-120F4	64.04	33.12	6.81	1.38	0.18	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	22.63	7.65	2.87	0.32	1.27	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	18.12	9.06	1.22	0.49	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.65	7.64	1.94	0.39	0.65	0.00
Placental Epithelial Cells, donor1	11278-116H9	99.01	41.61	2.63	0.48	1.67	0.24
Placental Epithelial Cells, donor2	11355-117H5	154.14	38.81	3.33	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	72.25	25.33	9.62	1.57	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	54.43	25.32	2.53	0.63	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	39.21	15.19	1.88	0.00	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.44	11.23	0.52	0.00	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	55.84	30.40	2.70	0.00	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	31.86	16.94	3.84	0.85	0.21	0.21
Preadipocyte - omental, donor2	11329-117E6	48.88	20.08	2.18	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	51.28	32.95	2.86	0.43	0.29	0.43
Preadipocyte - perirenal, donor1	11469-119C2	89.57	8.86	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	68.18	46.07	1.23	0.31	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	91.02	40.73	1.77	0.71	0.89	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	84.12	28.10	4.43	0.68	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	76.47	33.63	1.40	0.56	0.84	0.19
Preadipocyte - visceral, donor2	11357-117H7	65.35	28.99	1.38	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	89.65	30.20	1.57	0.84	0.73	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	1.81	5.58	0.75	0.30	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	17.47	18.28	1.49	0.27	0.27	0.14
Prostate Epithelial Cells, donor3	11404-118D9	5.57	3.18	0.37	0.43	0.12	0.31
Prostate Stromal Cells, donor1	11254-116F3	26.08	26.99	1.94	0.46	0.80	0.11
Prostate Stromal Cells, donor2	11332-117E9	35.14	26.00	2.33	1.26	0.72	0.18
Prostate Stromal Cells, donor3	11405-118E1	32.95	17.21	2.50	1.36	0.10	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	40.88	28.83	3.65	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.90	14.97	2.98	0.35	0.28	0.00
Renal Epithelial Cells, donor1	11517-119H5	83.69	81.66	3.55	1.01	0.51	1.01
Renal Epithelial Cells, donor2	11597-120H4	64.02	51.22	7.82	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.66	16.41	4.34	0.95	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	62.64	26.55	3.40	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	61.59	24.80	5.79	1.21	0.81	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	65.27	41.29	5.77	1.33	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	121.78	47.91	12.64	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	44.02	40.06	2.64	1.10	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	53.92	30.72	7.52	1.88	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	44.11	35.79	6.38	1.66	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	60.93	46.44	1.61	0.27	0.54	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	44.70	37.95	0.84	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	60.17	46.67	2.31	0.77	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	39.15	20.48	1.81	0.52	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.74	17.91	5.12	2.56	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	53.51	30.87	5.15	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.80	7.53	3.26	0.50	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	36.62	14.03	2.14	0.94	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	83.09	7.15	9.83	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	48.98	12.11	2.75	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	42.34	11.02	2.90	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	34.33	7.93	2.34	0.26	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	46.57	21.25	3.28	0.30	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	48.52	18.96	3.12	0.11	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	33.24	12.53	1.49	0.00	0.25	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	59.90	23.89	5.24	0.58	0.12	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	44.38	24.96	3.93	0.46	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	42.72	12.46	3.42	0.41	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	42.51	18.30	2.72	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	48.20	19.53	5.02	0.54	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	48.06	15.92	1.43	0.00	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	51.83	19.21	3.86	0.75	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	61.51	19.91	5.31	0.22	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	31.35	11.66	2.10	0.19	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	41.46	18.91	4.10	0.47	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	46.60	13.72	3.19	0.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	38.09	9.95	1.59	0.66	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	50.62	22.39	4.38	0.29	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	48.69	21.96	3.44	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	41.22	11.75	2.03	0.43	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	39.80	17.10	3.36	0.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	49.73	21.87	5.13	0.17	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	38.29	14.04	1.46	0.18	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	45.01	19.38	2.45	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	56.68	24.71	3.76	0.40	0.40	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	43.40	11.09	1.42	0.24	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	50.40	19.25	3.17	0.79	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	70.15	21.98	5.38	0.23	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	42.51	11.61	2.49	1.04	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	39.60	22.56	3.10	0.44	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	47.42	23.40	3.76	0.21	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	45.49	12.52	2.02	0.40	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	43.77	22.65	4.09	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	53.40	23.91	3.86	0.39	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	45.22	12.55	1.89	0.34	0.52	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	42.80	17.01	3.57	0.14	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	66.49	24.46	3.45	0.33	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	42.10	9.71	1.53	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	50.01	19.23	6.07	0.44	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	72.50	17.86	6.40	1.07	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	34.01	6.91	4.15	0.55	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	40.48	22.38	8.81	0.95	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	47.56	19.35	5.04	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	34.19	10.08	3.86	0.57	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	26.55	13.28	7.34	0.00	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	25.99	14.20	9.07	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	45.89	11.50	3.55	0.37	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	13.54	6.26	11.64	0.15	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	16.43	9.73	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	54.55	13.26	3.01	1.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.07	13.35	8.60	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	38.34	6.29	9.29	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.55	5.79	4.96	0.47	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	36.50	14.09	9.61	0.00	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	32.45	9.01	8.41	1.20	0.60	0.00
Schwann Cells, donor1	11498-119F4	139.92	39.68	7.33	1.32	0.38	0.38
Schwann Cells, donor2	11578-120F3	108.88	10.21	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	86.32	32.42	4.16	1.53	0.22	0.00
Sebocyte, donor1	11220-116B5	20.27	15.34	0.55	1.10	0.00	1.10
Sebocyte, donor2	11301-117B5	42.28	21.60	1.84	0.92	0.00	0.92
Sebocyte, donor3	11378-118B1	48.85	16.49	1.86	1.24	0.00	0.00
Sertoli Cells, donor1	11255-116F4	54.67	26.51	3.31	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	53.66	31.07	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	21.38	14.87	3.78	1.85	0.26	0.26
Skeletal Muscle Cells, donor2	11358-117H8	15.18	10.12	5.78	1.45	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	87.78	47.65	3.34	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	150.97	47.13	4.08	0.94	0.79	0.16
Skeletal Muscle Cells, donor5	11455-119A6	126.94	34.34	5.05	1.04	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	103.73	29.86	3.08	1.23	0.15	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	77.37	24.19	5.80	1.51	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	99.31	35.96	8.99	1.57	0.43	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	102.19	42.46	5.16	1.19	0.40	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.43	17.10	5.73	0.93	0.34	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	73.10	47.04	4.34	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	84.07	35.78	8.81	2.34	0.14	0.14
Skin - palm, donor1	10286-104F7	53.72	16.12	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	20.90	15.28	1.73	0.29	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	14.72	10.63	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.23	18.05	0.91	0.39	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	9.04	10.84	0.70	0.42	0.56	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	9.28	16.18	2.11	0.14	0.56	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	14.59	16.07	1.27	0.63	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	6.22	5.70	0.82	0.30	0.15	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	56.47	24.38	1.54	0.62	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.90	5.56	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	84.06	34.68	4.11	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	46.19	24.09	1.77	0.66	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	79.54	53.95	3.54	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	91.16	42.49	3.86	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	33.02	11.01	4.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	86.10	30.08	2.26	1.33	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	57.41	26.38	1.33	1.11	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	73.36	43.27	3.33	0.77	0.38	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	57.30	24.09	3.58	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	44.00	18.61	4.13	0.30	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	51.11	27.19	6.55	0.85	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	60.03	26.03	1.95	0.49	0.98	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.61	3.96	4.26	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	78.04	45.71	3.28	0.76	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	12.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	57.70	34.81	1.91	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	31.12	58.25	2.65	0.59	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	50.58	24.54	2.80	0.43	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	48.49	24.88	2.62	0.63	0.31	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	82.29	52.75	3.40	0.93	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	182.16	94.85	0.00	0.00	4.31	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	70.23	28.09	1.20	1.20	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	60.09	39.26	6.15	2.73	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	22.30	10.52	5.73	1.10	0.08	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	53.94	18.32	1.11	0.30	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	68.04	27.76	1.82	0.91	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	105.67	30.19	2.42	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	50.07	33.38	3.44	0.53	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	34.89	14.78	1.60	0.40	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	44.58	23.79	3.01	0.88	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	21.56	9.89	1.01	0.76	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	43.72	28.04	1.96	0.90	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	86.27	33.76	6.00	2.25	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	46.52	24.55	10.34	3.88	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	48.37	32.09	5.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	152.47	62.61	1.01	0.00	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	97.78	31.97	0.31	0.31	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	61.95	17.11	2.65	0.59	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	56.73	31.24	4.58	1.00	0.33	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	46.25	19.15	2.80	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	51.23	31.37	2.59	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	87.45	49.97	5.35	0.51	0.51	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	107.74	41.56	5.26	0.94	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	44.16	19.98	1.40	0.14	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	34.02	18.52	5.11	0.92	0.42	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	78.09	15.71	2.38	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	46.00	28.38	1.96	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	42.42	15.02	2.87	0.44	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	88.65	32.18	3.51	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	27.40	7.00	2.72	0.39	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	46.28	19.31	0.53	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	44.63	13.02	0.37	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	55.70	24.79	1.08	0.00	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	64.73	22.71	0.28	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	76.41	33.87	2.36	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	58.66	8.13	1.78	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	43.93	9.18	2.80	0.80	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	61.86	11.70	2.09	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	47.67	15.58	3.67	3.21	0.00	0.00
Synoviocyte, donor1	11291-117A4	32.65	17.51	1.01	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	63.53	20.79	0.67	0.50	0.34	0.00
Synoviocyte, donor3	11440-118H9	54.74	12.96	0.89	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	88.62	32.16	3.57	1.43	1.07	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	53.52	15.86	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	58.58	25.24	7.18	1.62	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	34.41	18.49	0.93	0.50	0.22	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	33.63	32.47	5.03	1.93	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	28.63	21.19	1.15	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	35.80	14.52	0.98	0.49	1.23	0.12
Urethra, donor2	10319-105A4	59.35	8.99	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	27.10	19.39	2.13	0.80	0.00	0.00
Urothelial Cells, donor2	11600-120H7	25.64	18.43	4.41	0.40	0.40	0.40
Urothelial Cells, donor3	11681-122H7	33.23	11.69	1.15	0.46	0.23	0.00
Urothelial cells, donor0	11216-116B1	18.72	6.46	2.45	0.67	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	26.69	8.90	0.89	0.00	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	24.30	8.58	0.00	0.00	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.12	9.58	1.37	0.00	6.85	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	31.33	8.61	2.07	0.00	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	38.93	9.88	1.16	0.00	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	11.45	7.29	0.00	0.00	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	38.55	5.51	0.92	0.92	5.51	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	34.69	18.26	0.00	0.00	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	30.84	37.13	3.82	2.34	0.12	0.37
Wilms' tumor cell line:HFWT	10597-108E3	22.88	22.00	8.80	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	79.05	48.04	1.40	1.12	0.00	1.96
achilles tendon, donor2	10292-104G4	31.00	10.33	4.13	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	53.29	17.34	4.59	2.29	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	146.50	65.47	0.93	0.93	0.46	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	40.48	23.27	0.59	0.36	0.00	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	146.67	121.63	0.54	0.00	0.54	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	135.48	34.57	0.28	0.28	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	182.51	46.95	4.02	0.42	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	17.15	6.26	0.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	63.45	13.66	0.00	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	100.05	12.25	2.04	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	211.62	31.84	1.94	1.16	0.39	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	22.26	18.95	0.18	0.00	0.37	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	132.62	35.10	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	90.40	55.77	1.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	100.19	43.50	0.52	0.26	0.26	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	88.26	35.95	2.92	0.29	0.88	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	70.18	30.21	5.11	1.39	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	165.32	19.33	5.76	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	36.53	18.72	2.15	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	36.70	27.31	0.43	0.00	0.00	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	26.69	20.62	1.82	0.30	0.30	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	44.77	22.63	1.20	0.48	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	153.24	40.98	2.23	0.22	1.11	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	84.05	42.36	3.34	0.67	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	102.20	74.33	14.87	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	323.93	153.30	5.27	0.00	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	252.96	48.41	7.41	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	241.81	78.73	13.12	0.00	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	82.66	23.55	0.47	1.41	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	25.28	4.96	0.62	0.31	0.62	0.16
adipose, donor1	10184-103D4	42.81	12.31	0.59	0.00	0.00	1.17
adipose, donor2	10185-103D5	85.56	10.14	6.08	2.84	0.00	0.00
adipose, donor3	10186-103D6	45.74	17.15	8.17	4.36	0.00	0.82
adipose, donor4	10187-103D7	38.14	14.73	6.07	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	115.37	40.40	1.26	1.74	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	50.93	10.91	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	54.16	8.00	2.80	0.27	0.40	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	105.05	54.67	2.14	0.36	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	62.14	13.22	0.93	0.23	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	100.42	24.34	8.45	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	59.51	11.49	0.29	0.00	0.88	0.00
amygdala - adult, donor10196	10167-103B5	155.34	21.34	5.93	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	107.87	28.39	2.03	0.81	0.61	0.20
amygdala, newborn, donor10223	10360-105E9	41.31	15.49	1.29	0.00	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	23.17	8.40	0.76	0.51	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	91.78	43.46	1.10	0.00	1.32	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	113.57	48.77	14.70	16.70	0.00	1.67
aorta, adult, pool1	10052-101G7	44.72	5.88	2.35	0.00	0.00	0.20
appendix, adult	10189-103D9	43.47	13.20	2.72	0.78	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	52.62	45.06	5.50	5.16	0.00	0.00
artery, adult	10190-103E1	81.52	12.23	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	30.28	20.72	9.85	3.48	0.29	0.00
b cell line:RPMI1788	10427-106D4	31.08	29.15	1.78	0.74	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	33.29	18.03	1.66	0.00	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	54.78	36.91	0.60	0.10	0.40	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	14.39	31.30	3.01	0.50	0.50	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	92.27	17.34	6.15	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	39.00	5.00	0.98	0.22	0.11	0.11
blood, adult, pool1	10053-101G8	19.93	11.07	2.21	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	67.65	24.83	0.86	0.86	0.86	0.00
bone marrow, adult	10192-103E3	20.24	7.42	4.05	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	56.38	20.50	1.03	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	58.69	19.15	1.34	0.11	0.33	0.22
brain, fetal, pool1	10085-102B4	74.80	13.36	5.34	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	29.73	71.36	2.64	0.00	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	11.73	5.74	0.75	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	41.04	6.94	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	45.99	23.12	2.29	1.02	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	110.39	17.63	3.40	1.24	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	31.31	20.95	1.15	0.69	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	83.04	30.50	1.69	0.24	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	88.86	10.34	1.41	0.94	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	22.09	21.33	1.31	0.55	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	67.82	24.40	0.63	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	58.83	19.16	6.92	1.33	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	116.28	23.03	2.30	0.00	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	101.40	32.29	1.17	0.50	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	200.97	49.67	1.53	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	54.93	15.02	1.10	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	139.84	5.83	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	45.48	13.45	5.12	1.28	1.49	0.21
cerebellum, adult, pool1	10083-102B2	102.79	11.73	2.07	1.03	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	44.84	16.61	9.13	4.15	0.83	0.00
cerebral meninges, adult	10188-103D8	100.10	27.48	3.53	0.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	55.55	16.08	0.00	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	51.19	28.33	0.72	0.00	0.14	0.58
cervical cancer cell line:ME-180	10553-107I4	34.14	26.18	0.83	0.00	0.00	0.50
cervix, adult, pool1	10013-101C4	33.28	9.13	3.25	0.84	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	51.00	28.43	4.18	0.70	0.84	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	16.98	2.61	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	4.35	7.33	0.99	1.74	0.12	0.25
choriocarcinoma cell line:SCH	10785-110H2	6.28	16.76	2.71	2.83	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	9.49	22.77	0.47	0.24	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	28.78	10.83	1.14	0.28	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	28.44	17.80	2.78	0.70	0.00	0.20
chorionic membrane cells, donor3	12240-129G8	22.53	7.14	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	145.41	49.48	0.00	0.00	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	41.49	15.94	3.46	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	93.13	23.44	4.86	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	13.61	12.33	1.80	0.00	1.28	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	19.35	16.45	1.94	0.48	0.48	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	14.25	12.83	2.24	0.00	0.41	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	25.03	30.92	2.36	0.29	0.29	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	109.72	35.45	1.82	0.00	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	29.94	29.03	0.00	0.23	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	12.15	17.35	0.52	0.17	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	6.96	13.00	0.37	0.18	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	44.09	10.26	0.76	1.90	0.38	0.38
colon, adult, donor1	10082-102B1	59.50	11.90	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	51.00	14.22	0.82	0.00	0.59	0.00
colon, fetal, donor1	10070-101I7	29.05	1.24	4.33	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	146.67	32.08	13.75	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	826.21	150.22	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	53.97	23.37	1.70	2.55	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	70.49	24.90	3.62	3.17	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	79.53	33.00	3.53	4.23	0.28	0.56
corpus callosum, adult, pool1	10042-101F6	68.33	16.47	1.22	0.00	0.22	0.11
cruciate ligament, donor2	10295-104G7	54.30	12.16	1.62	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	71.43	16.85	11.24	0.00	0.00	0.00
diencephalon, adult	10193-103E4	110.63	36.24	0.96	0.00	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	149.48	48.91	6.89	1.15	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	12.05	13.08	1.28	1.03	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.53	11.80	0.48	0.00	0.00	0.24
ductus deferens, adult	10196-103E7	39.87	13.46	1.50	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	15.84	10.08	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.90	17.66	4.41	2.94	1.47	0.00
dura mater, adult, donor1	10041-101F5	24.20	10.49	5.04	0.50	0.17	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	61.96	39.75	4.44	1.33	1.55	4.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	123.52	67.49	10.46	1.00	0.43	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	27.13	22.20	1.23	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	23.31	14.23	0.30	0.91	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	30.26	22.54	1.23	0.31	0.31	1.23
embryonic pancreas cell line:2C6	10603-108E9	17.08	28.90	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.48	26.15	2.68	0.67	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	50.93	17.76	1.99	1.45	0.18	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	80.57	72.37	1.45	1.13	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	25.01	14.90	0.78	0.33	0.67	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	32.67	21.45	0.33	0.22	0.11	0.66
epididymis, adult	10197-103E8	56.51	16.12	2.30	0.42	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	61.92	32.11	2.31	0.18	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	39.32	27.13	4.33	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	87.93	52.03	0.52	0.39	0.52	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	60.23	43.30	1.48	0.30	0.30	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	99.82	71.14	1.34	0.45	0.90	1.68
esophagus, adult, pool1	10015-101C6	37.37	11.57	0.96	0.32	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	18.79	23.29	27.30	3.38	0.38	0.25
eye - muscle inferior rectus, donor1	10272-104E2	26.56	16.90	0.00	0.00	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	67.33	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	77.39	16.37	4.46	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	65.35	13.76	1.15	1.15	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	29.15	17.49	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	49.32	15.51	3.56	1.78	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	51.03	31.54	1.92	0.38	0.00	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	86.42	49.86	4.99	1.42	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	62.67	25.43	2.81	0.19	0.47	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	118.30	76.26	4.80	0.30	1.20	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	26.52	16.92	4.39	1.28	0.18	0.09
gall bladder, adult	10198-103E9	70.02	11.35	6.04	1.21	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	103.08	13.42	2.68	0.00	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	78.06	12.33	2.61	0.00	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	25.98	26.40	1.06	0.63	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	37.52	24.18	2.51	0.00	0.19	0.77
gastric cancer cell line:AZ521	10549-107H9	70.34	92.96	1.48	2.79	0.33	0.98
gastric cancer cell line:GSS	10560-108A2	64.98	5.49	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	15.54	7.08	1.83	0.91	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	11.24	6.54	0.46	0.23	0.00	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	17.49	18.61	3.08	0.56	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	40.41	21.95	0.50	0.50	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	90.25	83.70	0.63	0.42	0.21	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	112.35	102.10	0.70	0.28	0.00	0.28
glioblastoma cell line:T98G	10485-107A8	83.44	20.86	2.43	0.22	0.22	0.11
glioma cell line:GI-1	10413-106B8	19.33	12.59	0.59	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	177.85	27.70	1.46	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	102.52	18.55	0.98	0.00	0.24	0.49
globus pallidus, adult, donor10258	10367-105F7	123.23	13.69	0.00	0.00	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	49.03	17.05	3.20	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	119.91	41.60	14.68	4.89	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	404.35	163.93	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	768.31	141.12	20.91	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	28.16	19.20	3.20	0.96	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	25.25	10.56	2.30	1.84	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	24.69	10.52	1.37	0.46	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	33.49	16.10	0.64	0.64	0.64	0.64
hIPS, biol_rep1	14380-156B6	27.31	5.75	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	34.29	16.46	4.12	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	110.35	22.07	3.31	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	62.07	18.39	3.16	2.30	0.57	0.00
heart - mitral valve, adult	10205-103F7	42.45	11.96	2.39	0.60	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	44.19	17.00	3.66	0.26	0.78	0.00
heart - tricuspid valve, adult	10207-103F9	15.82	15.82	1.67	0.00	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	49.38	24.49	1.43	3.26	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	85.17	23.85	0.43	0.00	1.70	0.00
heart, adult, pool1	10016-101C7	76.58	24.38	1.15	0.46	0.69	0.23
heart, fetal, pool1	10046-101G1	37.68	12.73	2.57	0.72	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	34.55	10.18	7.10	1.54	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	4.76	17.84	5.95	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	31.60	40.11	0.33	0.33	0.11	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	29.13	42.48	0.12	0.36	0.24	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.54	38.00	0.40	0.00	0.10	1.11
hepatoma cell line:Li-7	10484-107A7	10.79	16.35	1.22	0.11	0.33	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	92.66	38.59	3.52	0.70	0.00	0.30
hippocampus - adult, donor10196	10169-103B7	107.88	17.98	1.89	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	83.48	22.45	1.63	0.00	0.61	0.00
hippocampus, adult, donor10258	10374-105G5	122.99	17.43	0.50	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	33.49	16.57	2.47	1.41	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	59.81	38.45	0.61	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	45.16	31.42	1.77	0.20	0.20	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	52.30	28.18	2.03	0.00	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.12	7.33	2.82	2.26	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	21.43	9.30	2.07	2.07	0.00	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	20.12	15.56	3.04	1.52	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	28.90	17.52	7.59	1.46	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	28.01	14.22	6.68	3.66	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.86	17.93	4.59	4.17	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	36.70	38.83	10.66	4.03	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	36.00	36.32	9.48	3.38	0.00	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	43.09	37.70	11.45	4.04	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	80.43	46.95	0.94	0.63	0.16	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	98.75	39.79	0.49	0.00	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	88.15	58.47	0.00	0.00	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	43.15	13.55	2.10	1.53	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	44.48	14.39	3.05	2.62	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	66.47	16.49	2.00	1.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	55.39	10.55	6.03	2.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	54.11	15.92	1.36	3.64	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	72.36	15.66	7.20	2.51	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	67.61	31.52	12.08	5.55	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	58.93	22.64	7.55	3.48	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	84.00	32.88	11.06	7.47	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	48.03	35.66	2.03	0.55	0.74	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	52.49	25.39	3.71	0.57	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	64.92	35.52	2.04	0.82	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	23.94	9.15	4.58	2.82	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	23.44	11.09	2.85	1.58	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	27.84	10.29	3.63	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.92	10.34	4.65	2.07	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	27.89	9.96	11.95	1.33	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	33.35	20.52	6.16	2.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	37.32	28.12	7.67	2.81	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	53.76	24.23	8.33	3.79	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	54.11	32.26	15.12	2.69	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	44.92	33.57	1.21	0.97	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	55.26	40.55	0.45	1.78	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	59.02	25.85	0.49	0.98	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	19.25	11.00	4.89	1.53	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	22.77	6.51	6.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	24.82	14.56	0.66	1.65	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.10	16.97	6.57	2.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	36.19	14.11	7.24	2.17	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	26.33	17.44	6.41	1.78	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	34.61	26.25	8.35	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.41	20.86	9.34	3.66	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	45.53	23.98	11.58	3.50	0.00	0.27
immature langerhans cells, donor1	11904-125F5	22.28	2.42	0.48	0.00	0.48	0.00
immature langerhans cells, donor2	11905-125F6	25.35	3.96	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	73.25	26.97	3.22	0.28	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	128.43	33.17	8.45	4.55	0.00	0.65
kidney, adult, pool1	10017-101C8	44.46	31.34	0.80	0.00	0.40	0.10
kidney, fetal, pool1	10045-101F9	32.68	24.33	8.28	1.98	0.42	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.24	16.33	8.66	1.70	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	48.11	17.97	0.55	1.38	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.83	13.03	1.28	0.37	0.37	0.37
left atrium, adult, donor1	10079-102A7	65.93	10.35	5.45	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	60.68	9.61	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	78.25	49.25	2.46	0.00	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	67.18	28.02	0.72	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	55.98	29.89	1.63	1.09	1.09	0.00
leiomyoma cell line:15425	10571-108B4	45.89	25.98	0.73	0.49	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	82.54	31.75	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	55.41	61.69	0.00	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	75.68	42.97	1.65	0.47	0.47	0.24
liposarcoma cell line:KMLS-1	10782-110G8	83.88	25.77	2.34	0.16	0.62	0.00
liposarcoma cell line:SW 872	10726-110A6	38.01	19.37	7.55	3.41	0.00	0.12
liver, adult, pool1	10018-101C9	50.73	18.80	1.46	0.00	0.49	0.00
liver, fetal, pool1	10086-102B5	25.40	16.93	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	75.83	21.44	1.46	0.73	0.58	0.00
locus coeruleus, adult, donor10252	10165-103B3	84.16	23.44	1.11	0.37	1.11	0.18
locus coeruleus, adult, donor10258	10375-105G6	135.71	20.88	1.13	0.00	0.85	0.28
locus coeruleus, newborn, donor10223	10362-105F2	28.18	18.93	0.42	0.84	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	33.77	32.52	0.83	0.14	0.14	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	95.14	66.18	6.89	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	36.38	22.94	2.77	0.79	0.13	0.26
lung, adult, pool1	10019-101D1	30.48	8.74	0.71	0.71	0.35	0.00
lung, fetal, donor1	10068-101I5	52.80	7.99	3.42	2.00	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	45.82	10.08	4.58	0.92	0.46	0.00
lymph node, adult, donor1	10077-102A5	45.92	7.10	0.95	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	45.59	20.60	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	33.96	15.85	3.62	0.60	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	18.69	16.14	0.00	0.00	0.00	1.70
mature adipocyte, donor1	12231-129F8	63.49	15.98	1.33	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	70.35	13.07	0.42	0.00	0.62	0.21
mature adipocyte, donor3	12233-129G1	52.39	14.22	0.47	0.00	0.47	0.24
mature adipocyte, donor4	12234-129G2	45.80	11.06	0.00	0.00	1.05	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	17.63	18.35	0.71	0.24	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	148.90	29.33	3.38	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	77.06	22.07	2.21	0.18	0.74	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	201.73	32.72	1.59	0.95	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	20.47	14.07	0.00	0.00	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	176.51	39.83	4.05	0.68	0.68	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	93.17	22.50	1.70	1.06	0.85	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	217.67	5.78	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	43.06	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	39.48	17.59	1.08	0.72	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	112.27	15.58	0.65	0.65	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	63.93	19.20	0.93	0.15	0.77	0.46
medulla oblongata, adult, pool1	10038-101F2	45.71	14.53	1.22	0.16	0.82	0.16
medulla oblongata, newborn, donor10223	10361-105F1	53.12	13.54	1.39	0.35	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	20.81	18.38	2.44	1.55	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	24.09	16.87	1.47	0.61	0.37	0.12
melanoma cell line:COLO 679	10514-107E1	19.84	18.83	4.74	0.72	0.00	0.14
melanoma cell line:G-361	10465-106H6	12.76	7.06	0.27	0.27	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	45.77	11.76	1.81	0.54	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	124.24	74.02	0.88	2.64	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	166.94	79.32	1.56	1.04	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	90.37	41.58	2.15	0.61	0.31	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	23.45	13.09	2.00	1.27	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	47.21	28.16	0.83	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	33.85	10.82	0.56	0.42	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	51.99	20.22	1.35	1.93	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	83.98	15.27	1.39	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	22.48	14.07	1.54	0.51	1.03	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.37	13.69	1.27	0.81	0.35	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	49.87	27.46	0.93	1.06	1.06	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	35.25	24.04	2.16	0.27	0.81	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	32.72	18.78	0.71	0.14	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	11.86	9.88	2.31	0.99	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	50.37	26.98	3.04	0.97	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	67.72	24.78	0.35	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	46.55	14.29	2.86	0.61	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	37.74	14.02	1.44	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	32.38	13.45	1.34	0.93	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	44.00	20.98	1.37	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.53	17.20	1.68	0.42	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	38.55	16.29	3.14	0.75	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.17	17.68	0.79	0.35	0.18	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.45	10.68	1.10	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	40.63	17.17	1.14	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	75.36	22.31	2.11	1.26	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	62.56	26.49	0.00	1.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	45.79	24.30	1.02	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	50.78	24.61	1.05	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	49.29	26.19	2.16	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.01	22.59	2.59	0.94	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	56.52	18.95	3.38	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.12	23.19	2.75	0.79	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	45.88	21.78	1.85	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	96.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	55.09	26.82	3.17	0.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	47.30	22.98	1.56	0.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	50.71	19.47	1.44	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	45.47	24.93	2.93	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	48.67	22.49	2.69	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	49.13	24.97	2.05	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	55.84	25.77	3.01	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	95.70	19.14	8.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	25.82	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	63.33	31.83	0.97	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	48.01	32.01	4.36	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	79.43	28.25	4.26	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	77.69	30.26	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	66.08	29.15	2.33	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	86.05	16.79	4.20	2.10	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	70.54	20.86	0.00	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	33.37	9.53	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	67.01	25.50	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	65.80	20.71	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	70.31	27.87	3.17	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	64.84	18.28	2.76	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	23.64	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	19.96	11.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	71.71	11.41	2.85	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	55.61	19.07	3.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	74.28	12.38	3.54	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	74.50	8.42	3.43	0.94	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	81.54	17.38	2.67	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	60.32	8.28	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	25.68	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	68.15	16.52	2.75	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	64.32	33.65	2.47	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	85.23	28.04	2.24	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	81.42	26.08	0.64	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	101.15	42.31	2.42	0.81	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	95.95	41.43	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	131.77	35.48	0.00	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	35.81	17.60	0.61	0.00	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	18.08	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	58.48	32.95	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	80.76	21.03	1.39	0.79	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	62.30	20.44	1.30	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	56.02	19.35	3.06	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	11.61	3.09	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	50.32	32.84	1.18	0.47	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	39.38	34.98	4.17	0.46	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	25.64	0.00	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	78.30	106.86	2.57	1.03	1.13	0.62
mesothelioma cell line:Mero-25	10850-111F4	13.39	12.94	0.68	0.00	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	27.14	26.65	1.71	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	63.99	33.44	1.77	0.44	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	25.75	16.82	1.84	0.53	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	41.70	23.83	1.02	0.17	0.34	0.51
mesothelioma cell line:Mero-84	10855-111F9	52.32	70.27	2.53	1.01	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	35.20	22.15	4.76	0.41	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	38.43	20.37	0.66	0.33	0.33	0.66
mesothelioma cell line:NCI-H226	10846-111E9	20.63	37.47	2.35	0.36	0.36	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	35.19	24.77	0.17	0.00	0.17	0.68
mesothelioma cell line:NCI-H28	10845-111E8	48.35	59.55	0.25	0.00	0.51	0.76
mesothelioma cell line:No36	10857-111G2	70.13	41.43	1.96	0.98	0.00	1.30
mesothelioma cell line:ONE58	10858-111G3	18.42	11.11	0.81	0.00	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	15.74	8.06	0.38	4.41	0.96	0.19
migratory langerhans cells, donor2	11902-125F3	13.92	6.72	2.81	2.44	0.73	0.00
migratory langerhans cells, donor3	11903-125F4	19.38	7.36	4.31	2.87	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.89	15.67	4.57	1.63	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	0.21	0.00	10.60	4.45	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7.14	14.28	1.61	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.63	12.37	3.23	1.52	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	51.19	14.97	4.07	0.18	0.18	0.37
myeloma cell line:PCM6	10474-106I6	43.68	13.64	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	42.61	47.18	1.52	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	25.89	13.93	1.18	0.00	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.59	6.02	0.00	0.00	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	13.83	6.55	0.22	0.00	0.15	0.22
nasal epithelial cells, donor2	12227-129F4	11.04	5.52	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	27.38	27.84	1.38	3.22	0.23	1.15
neuroblastoma cell line:NB-1	10539-107G8	142.00	89.99	10.29	3.18	1.12	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	91.95	40.91	1.27	1.27	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	12.49	13.04	2.80	0.75	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.33	13.76	2.61	4.74	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	50.52	22.33	3.33	1.27	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	128.20	74.06	2.42	1.21	0.20	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	54.68	38.78	0.64	1.27	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	38.86	26.62	6.92	1.06	0.00	0.00
neutrophil PMN, donor1	12133-128D9	44.62	14.87	0.00	0.00	44.62	0.00
neutrophil PMN, donor2	12137-128E4	79.68	39.84	0.00	0.00	26.56	0.00
neutrophil PMN, donor3	12141-128E8	85.24	18.94	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	36.87	10.15	5.75	1.69	0.00	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	210.53	66.44	4.00	1.60	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	60.27	19.24	7.05	2.24	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	37.31	19.97	0.79	0.26	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	60.84	26.06	2.06	0.47	0.66	0.28
occipital cortex - adult, donor10196	10172-103C1	193.68	26.78	6.18	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	85.61	18.25	2.68	0.27	1.34	0.54
occipital cortex, newborn, donor10223	10355-105E4	30.21	17.83	0.73	0.36	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	72.16	18.11	2.36	0.00	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	33.47	15.45	7.29	3.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	63.31	29.57	1.89	0.32	0.24	0.32
olfactory region, adult	10195-103E6	74.13	23.50	1.72	0.38	0.76	0.00
optic nerve, donor1	10277-104E7	80.04	16.01	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.82	12.19	3.08	0.46	0.23	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	51.25	11.40	0.41	1.10	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	43.18	30.31	0.51	0.34	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.28	15.82	2.19	1.27	0.12	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	36.75	19.70	1.47	0.59	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	108.38	39.24	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	48.35	48.99	14.21	1.91	0.21	0.42
ovary, adult, pool1	10020-101D2	23.32	6.38	2.10	1.05	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.95	21.27	2.57	0.73	0.18	0.00
pancreas, adult, donor1	10049-101G4	66.79	24.46	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.06	6.71	0.56	0.56	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	46.85	18.91	1.87	0.17	0.00	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	9.27	3.81	0.33	0.17	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	53.54	21.78	1.56	0.09	0.37	0.18
parietal cortex, adult, donor10258	10373-105G4	100.56	30.09	1.47	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	110.98	17.87	3.76	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	74.96	23.37	2.28	1.14	2.00	0.86
parietal lobe, adult, pool1	10034-101E7	57.45	23.88	1.85	0.26	0.26	0.35
parietal lobe, fetal, donor1	10072-101I9	91.16	17.46	6.79	8.73	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	35.52	17.57	0.75	0.75	0.37	0.00
parotid gland, adult	10199-103F1	96.20	17.27	1.23	0.62	4.32	0.62
penis, adult	10200-103F2	52.10	13.96	1.61	0.54	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	66.75	26.96	1.12	1.67	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	44.44	42.54	5.97	0.87	0.29	0.29
pineal gland - adult, donor10196	10179-103C8	61.92	13.55	3.87	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	56.26	17.77	5.92	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	107.23	22.57	2.51	0.00	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	95.11	18.21	1.01	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	87.56	15.11	2.61	1.56	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	92.79	21.28	2.55	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	19.24	14.41	1.18	0.75	0.75	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	20.53	11.26	1.46	0.40	0.40	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	30.51	9.49	1.09	0.31	0.47	0.00
pons, adult, pool1	10033-101E6	42.86	17.56	1.20	0.17	0.34	0.34
postcentral gyrus, adult, pool1	10032-101E5	70.26	28.59	1.74	0.35	0.26	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	29.28	18.82	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	302.94	137.70	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	305.13	152.56	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	57.83	35.98	0.73	1.60	0.15	0.29
prostate cancer cell line:PC-3	10439-106E7	201.10	92.93	2.36	0.18	0.54	0.91
prostate, adult, pool1	10022-101D4	36.73	8.71	2.99	0.27	0.18	0.00
putamen, adult, donor10196	10176-103C5	137.39	56.66	2.60	0.47	0.24	0.47
putamen, adult, donor10252	10152-102I8	205.88	37.25	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	75.40	13.11	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	102.93	53.64	0.72	0.00	0.48	0.48
putamen, newborn, donor10223	10365-105F5	29.99	23.24	1.50	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	12.80	10.47	1.16	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	86.24	22.26	22.26	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	44.94	13.14	2.76	0.21	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	24.85	1.66	0.41	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	56.26	17.39	5.07	0.99	0.40	0.00
retinoblastoma cell line:Y79	10475-106I7	45.21	17.15	1.56	4.42	0.00	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	55.08	42.91	5.78	2.70	0.00	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	39.09	33.74	6.47	1.69	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.17	15.91	10.61	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	36.74	9.55	0.65	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	38.97	8.12	0.41	0.14	0.00	0.14
salivary acinar cells, donor3	11773-123I9	52.30	7.28	0.00	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	47.47	8.01	1.14	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	20.99	10.88	1.60	0.59	0.25	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	31.03	13.87	1.53	0.82	0.12	0.24
seminal vesicle, adult	10201-103F3	97.35	9.52	5.82	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.31	20.16	0.49	0.00	0.97	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	46.30	8.81	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	48.17	19.07	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	4.70	13.16	0.67	1.21	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	28.74	14.59	0.55	0.11	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	41.03	27.87	0.65	0.26	0.90	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	108.53	15.61	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	62.97	15.47	0.60	0.12	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	33.17	10.05	7.04	4.02	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	0.00	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	47.97	15.78	2.52	4.42	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	207.12	37.02	3.34	1.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	85.11	35.62	9.46	3.15	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	237.08	100.23	1.16	5.40	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	33.62	23.08	1.81	0.49	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	64.50	23.32	1.29	2.73	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	58.84	27.02	1.53	0.22	0.00	0.65
small intestine, adult, pool1	10024-101D6	27.35	13.02	0.96	0.24	1.67	0.00
small intestine, fetal, donor1	10064-101I1	26.78	14.25	9.83	0.74	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	60.01	8.21	0.51	0.00	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	50.66	5.94	0.78	0.52	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	17.42	10.72	0.54	0.00	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	104.84	16.29	1.61	0.00	0.46	0.23
spinal cord, adult, donor10252	10159-103A6	56.77	7.10	0.39	0.39	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	108.61	15.91	0.00	0.69	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	73.79	26.22	7.32	3.05	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	47.76	14.24	0.00	0.46	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	35.10	22.70	4.48	0.45	0.15	0.00
spleen, adult, pool1	10025-101D7	42.29	16.41	1.65	0.00	0.11	0.00
spleen, fetal, pool1	10044-101F8	26.86	13.51	5.32	0.79	0.64	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	16.35	16.25	0.21	0.00	0.10	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	27.34	15.19	1.90	3.04	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	59.06	34.95	2.10	5.24	0.00	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.56	5.08	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	19.02	15.08	0.34	0.00	0.23	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	69.05	17.37	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	52.04	23.69	5.50	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	20.29	17.09	19.22	6.41	1.07	0.00
submaxillary gland, adult	10202-103F4	42.16	11.96	1.71	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	325.64	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	82.04	17.66	0.21	0.21	0.42	0.83
substantia nigra, adult, donor10258	10371-105G2	110.69	21.21	0.00	0.00	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	43.10	5.65	2.12	1.41	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	60.98	32.10	5.73	1.38	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	84.94	38.57	2.63	0.85	0.59	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	29.20	25.64	4.99	3.56	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	35.16	18.90	2.20	3.08	0.00	0.00
tenocyte, donor1	11763-123H8	75.75	27.93	3.14	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	69.82	19.08	3.05	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	63.01	32.25	1.48	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	62.89	20.74	1.53	1.02	0.68	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	30.06	11.25	9.87	2.00	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	28.83	12.55	0.62	0.15	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.26	26.02	0.76	0.38	0.13	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	17.77	9.83	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.98	7.09	0.00	0.11	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	17.91	12.70	0.33	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	19.97	15.25	1.07	4.08	0.32	7.09
testis, adult, pool2	10096-102C6	19.85	22.10	1.80	12.63	0.90	23.91
thalamus - adult, donor10196	10168-103B6	143.52	23.18	3.31	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	78.30	17.66	1.09	0.00	0.31	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	167.82	26.17	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	117.75	15.48	0.66	0.33	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	35.09	14.96	0.58	0.58	1.15	0.00
throat, adult	10209-103G2	55.18	18.97	1.50	0.00	0.25	0.00
throat, fetal, donor1	10061-101H7	51.80	20.11	8.53	1.22	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	128.58	28.62	0.99	3.78	0.20	0.20
thymus, adult, pool1	10027-101D9	34.89	16.30	1.49	0.30	0.50	0.00
thymus, fetal, pool1	10043-101F7	22.34	13.40	3.43	1.45	0.10	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	28.45	31.51	1.46	0.13	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	110.08	56.30	1.96	0.98	0.42	0.14
thyroid, adult, pool1	10028-101E1	28.18	28.74	1.68	0.28	0.93	0.00
thyroid, fetal, donor1	10060-101H6	40.34	29.00	6.33	1.58	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	6.16	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	89.08	19.07	1.16	0.00	0.23	0.00
tongue, fetal, donor1	10059-101H5	128.87	28.77	3.55	2.36	0.39	0.39
tonsil, adult, pool1	10047-101G2	36.26	16.53	2.00	0.70	0.30	0.10
trachea, adult, pool1	10029-101E2	23.64	14.23	0.82	0.25	0.16	0.00
trachea, fetal, donor1	10058-101H4	46.16	10.39	6.54	0.77	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	51.02	19.84	1.42	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	38.91	20.26	0.51	0.51	0.00	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	27.73	14.26	2.04	0.31	0.16	0.16
tridermal teratoma cell line:HGRT	10694-109G1	45.66	36.15	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	19.55	13.46	0.85	0.17	0.34	0.00
umbilical cord, fetal, donor1	10057-101H3	45.90	8.35	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	33.96	7.00	2.39	1.02	0.68	0.51
uterus, fetal, donor1	10055-101H1	44.03	16.89	8.70	2.56	0.00	0.51
vagina, adult	10204-103F6	27.79	5.17	2.58	0.65	0.65	0.00
vein, adult	10191-103E2	57.21	12.93	1.75	0.66	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.76	25.37	1.07	0.80	0.00	0.27

Property "Nearest transcripts" (as page type) with input value "ENST00000333775.9:63 BC033861:63 ENST00000575208.2:-145 ENST00000575071.5:355 BC006407:355 ENST00000575771.6:358 NM_032356.6:358 NM_001320924.3:358 NM_001320925.4:358 BC059944:426 KJ903414:454 KJ904915:454 AF530060:454 CU687386:454 KJ894981:494 DQ893290:494 DQ893319:494 DQ896634:494" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.